Basic information
Biomarker: BMP-10
Histology type: endometrial carcinoma
Cohort characteristics
Country: China
Region: Wuhan
Study type: retrospective study
Followed up time :
Subgroup 1 name : High expression
Subgroup 1 number: 63
Subgroup 2 name: Low expression
Subgroup 2 number: 80
Total number | Group I | Group I number | Group II | Group II number | Group III | Group III number | Group IV | Group IV number |
---|---|---|---|---|---|---|---|---|
143 | high BMP-10 expression | 63 | low BMP-10 expression | 80 |
Sample information
Conclusion: BMP-10 can be adopted as a molecular marker for predicting the poor prognosis of patients with EC.
Sample type : tissue
Sample method: immunohistochemistry
Expression pattern : high expression(>3)
Expression elevation: According to the proportion of positive tumor cells, the staining was scored as follows: “0” points, the proportion was<10%; “1” point, the proportion was between 10 and 33%; “2” points, the proportion was between 34 and 66%; “3” points, the proportion was between 67 and 100%. The staining intensity was scored as follows: in at least fve diferent high-power felds, 0 points, negative; 1 point, weak; 2 points, moderate; 3 points, strong. The protein expression of BMP-10 was classifed semi-quantitatively according to the total score of the proportion of stained positive tumor cells and staining intensity. A score between 0 and 3 points indicated low expression (low expression group) and a score higher than 3 points indicated high expression (high expression group).
Disease information
Statictics: cutoff<60;cutoff>60
Cohort age: 103;40
Subgroup 1 age: 44;19
Subgroup 2 age: 59;21
Related information
Funtion Uniprot: Required for maintaining the proliferative activity of embryonic cardiomyocytes by preventing premature activation of the negative cell cycle regulator CDKN1C/p57KIP and maintaining the required expression levels of cardiogenic factors such as MEF2C and NKX2-5. Acts as a ligand for ACVRL1/ALK1, BMPR1A/ALK3 and BMPR1B/ALK6, leading to activation of SMAD1, SMAD5 and SMAD8 transcription factors. Inhibits endothelial cell migration and growth. May reduce cell migration and cell matrix adhesion in breast cancer cell lines.
UniProt ID: O95393
UniProt Link: https://www.uniprot.org/uniprotkb/O95393/entry
Biological function from UniProt: #Cell adhesion
Molecular function from UniProt:
Tissue specificity from UniProt: Detected in mammary epithelia (at protein level)
Subcellular UniProt: #Secreted
Recommended name: Bone morphogenetic protein 10
Gene name from HGNC: BMP10
AlphaFold DB: O95393
AlphaFold Link: https://alphafold.ebi.ac.uk/entry/O95393
Induction: Down-regulated in some breast cancer subtypes and breast cancer cell lines.
HPA link: https://www.proteinatlas.org/ENSG00000163217-BMP10
Tissue specificity RNA from HPA: Tissue enriched (heart muscle)
Single cell type specificity Not detected
Immune cell specificity: Not detected in immune cells
Cancer prognostic summary HPA Gene product is not prognostic
Pathology link: https://www.proteinatlas.org/ENSG00000163217-BMP10/pathology
Pathology endo: https://www.proteinatlas.org/ENSG00000163217-BMP10/pathology/endometrial+cancer
OMIM: 608748
OMIM link2: https://www.omim.org/entry/608748
HGNC ID: HGNC:20869
HGNC link: https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:20869